These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27113779)

  • 1. Decrease in Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-1 Ratio in the First Week of Stroke Is Related to Positive Outcomes.
    Mattlage AE; Rippee MA; Sandt J; Billinger SA
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1800-1806. PubMed ID: 27113779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 predict Three-months Outcome after Ischemic Stroke.
    Armbrust M; Worthmann H; Dengler R; Schumacher H; Lichtinghagen R; Eschenfelder CC; Endres M; Ebinger M
    Exp Clin Endocrinol Diabetes; 2017 Jul; 125(7):485-491. PubMed ID: 28724170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly.
    Denti L; Annoni V; Cattadori E; Salvagnini MA; Visioli S; Merli MF; Corradi F; Ceresini G; Valenti G; Hoffman AR; Ceda GP
    Am J Med; 2004 Sep; 117(5):312-7. PubMed ID: 15336580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating insulin-like growth factor binding protein-3 predicts one-year outcome after ischemic stroke.
    Ebinger M; Ipsen N; Leonards CO; Empl L; Hanne L; Liman T; Mai K; Strasburger CJ; Spranger J; Endres M
    Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):461-5. PubMed ID: 26069074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Prestroke Peak VO2 Is Related to Circulating IGF-1 Levels During Acute Stroke.
    Mattlage AE; Rippee MA; Abraham MG; Sandt J; Billinger SA
    Neurorehabil Neural Repair; 2017 Jan; 31(1):65-71. PubMed ID: 27377914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor I serum levels influence ischemic stroke outcome.
    De Smedt A; Brouns R; Uyttenboogaart M; De Raedt S; Moens M; Wilczak N; Luijckx GJ; De Keyser J
    Stroke; 2011 Aug; 42(8):2180-5. PubMed ID: 21700939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.
    Paolisso G; Ammendola S; Del Buono A; Gambardella A; Riondino M; Tagliamonte MR; Rizzo MR; Carella C; Varricchio M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2204-9. PubMed ID: 9215295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
    Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous tissue plasminogen activator in patients with stroke increases the bioavailability of insulin-like growth factor-1.
    Wilczak N; Elting JW; Chesik D; Kema IP; De Keyser J
    Stroke; 2006 Sep; 37(9):2368-71. PubMed ID: 16902174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-Like Growth Factor-I, Insulin-Like Growth factor Binding Protein-3 and Blood Hemoglobin Concentration in an Elderly Population.
    Duron E; Vidal JS; Funalot B; Brunel N; Viollet C; Rigaud AS; Labourée F; Epelbaum J; le Bouc Y; Hanon O
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):854-9. PubMed ID: 25384548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.
    Mikami K; Ozasa K; Nakao M; Miki T; Hayashi K; Watanabe Y; Mori M; Sakauchi F; Washio M; Kubo T; Suzuki K; Wakai K; Nakachi K; Tajima K; Ito Y; Inaba Y; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():57-61. PubMed ID: 20553083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered levels of circulating insulin-like growth factor I (IGF-I) following ischemic stroke are associated with outcome - a prospective observational study.
    Åberg ND; Åberg D; Jood K; Nilsson M; Blomstrand C; Kuhn HG; Svensson J; Jern C; Isgaard J
    BMC Neurol; 2018 Aug; 18(1):106. PubMed ID: 30081862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
    Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
    Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.